XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,788,000 | -27.2% | 550,000 | -17.9% | 0.04% | -23.2% |
Q2 2023 | $25,795,000 | -3.9% | 670,000 | -10.7% | 0.06% | -6.7% |
Q1 2023 | $26,842,500 | -6.1% | 750,000 | +3.4% | 0.06% | -11.8% |
Q4 2022 | $28,586,750 | +17.3% | 725,000 | +7.4% | 0.07% | +13.3% |
Q3 2022 | $24,368,000 | +27.1% | 675,000 | +7.1% | 0.06% | +36.4% |
Q2 2022 | $19,165,000 | -3.6% | 630,000 | -3.1% | 0.04% | +15.8% |
Q1 2022 | $19,871,000 | -4.4% | 650,000 | -2.3% | 0.04% | +2.7% |
Q4 2021 | $20,775,000 | +15.7% | 665,000 | -43.4% | 0.04% | +5.7% |
Q3 2021 | $17,954,000 | -36.8% | 1,175,000 | -23.0% | 0.04% | -37.5% |
Q2 2021 | $28,396,000 | -37.8% | 1,525,000 | -40.2% | 0.06% | -39.8% |
Q1 2021 | $45,645,000 | +21.1% | 2,550,000 | +4.1% | 0.09% | +13.4% |
Q4 2020 | $37,681,000 | +38.9% | 2,450,000 | 0.0% | 0.08% | +20.6% |
Q3 2020 | $27,122,000 | +6.8% | 2,450,000 | +21.0% | 0.07% | +4.6% |
Q2 2020 | $25,394,000 | +10.6% | 2,025,000 | 0.0% | 0.06% | -5.8% |
Q1 2020 | $22,964,000 | -9.0% | 2,025,000 | +5.2% | 0.07% | +11.3% |
Q4 2019 | $25,237,000 | +115.5% | 1,925,000 | +48.1% | 0.06% | +113.8% |
Q3 2019 | $11,713,000 | -8.6% | 1,300,000 | 0.0% | 0.03% | -9.4% |
Q2 2019 | $12,818,000 | -3.0% | 1,300,000 | 0.0% | 0.03% | -3.0% |
Q1 2019 | $13,208,000 | +61.0% | 1,300,000 | 0.0% | 0.03% | +43.5% |
Q4 2018 | $8,203,000 | -48.2% | 1,300,000 | +8.3% | 0.02% | -34.3% |
Q3 2018 | $15,840,000 | +115.2% | 1,200,000 | +50.0% | 0.04% | +105.9% |
Q2 2018 | $7,360,000 | – | 800,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |